Monzo and Starling diverge on European expansion plans June 5, 2024 The UK's two leading digital-only banks are diverging in their approach to international expansion as they target new markets ahead of expected stock market listings.
Sour year for VK and Hooch maker as price rises fail to offset costs jump June 5, 2024 The maker of alcoholic drinks such as VK and Hooch saw its profit slashed as its costs surged despite the group raising prices.
Octopus Energy inks landmark agreement with Gresham House Energy Storage Fund June 5, 2024 Gresham House Energy Storage Fund has reached an important agreement with Octopus Energy.
Sketch: ITV leaders debate was political ‘pinball machine’ June 5, 2024 The first chance to witness Keir Starmer and Rishi Sunak tear chunks, or at least nuggets, out of one another came during the ITV leaders debate.
Angle: Pharma firm’s share price plunges after missing market forecasts June 5, 2024 Angle also today announced a plan to raise about £8.5m through a combination of new share placements and subscriptions.
London data firm Preqin exploring sale at £1bn-plus valuation June 5, 2024 Financial data group Preqin is reportedly exploring a sale that could value the firm in excess of £1bn in the latest sign of consolidation in the sector.
Royal Opera House: Streaming success for London icon as it battles to ‘fortify’ finances June 5, 2024 London's Royal Opera House returned to the black after its box office takings jumped and its streaming platform surged in popularity.
VP profit falls as Brandon Hire Station and housebuilding woes drag on results June 5, 2024 Pre-tax profit fell 90.9 per cent, in large part down to the impact of £27.7m of non-cash impairment at VP's subsidiary, Brandon Hire Station
Workspace: Flexible office provider calls market bottom as workers return to the City June 5, 2024 Flexible office provider Workspace said its “future is bright” after it revealed a 8.7 per cent increase in profit for the year to March.
Astrazeneca swallows up Canada-based Fusion Pharmaceuticals in £1.5bn move June 5, 2024 Astrazeneca has completed its $2bn (£1.5bn) acquisition of Canada-based Fusion Pharmaceuticals, in a deal first announced in March.